Literature DB >> 5221351

Defects of neuromuscular transmission in syndromes other than myasthenia gravis.

E H Lambert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5221351     DOI： 10.1111/j.1749-6632.1966.tb45484.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  17 in total

1.  Evaluation of antiviral therapies in respiratory and neurological disease models of Enterovirus D68 infection in mice.

Authors:  Brett L Hurst; W Joseph Evans; Donald F Smee; Arnaud J Van Wettere; E Bart Tarbet
Journal:  Virology       Date:  2018-10-31       Impact factor: 3.616

2.  Abnormalities of autonomic function in the Lambert Eaton myasthenic syndrome.

Authors:  J P Heath; D J Ewing; R E Cull
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-03       Impact factor: 10.154

3.  4-aminopyridine--a new drug tested in the treatment of Eaton-Lambert syndrome.

Authors:  H Lundh; O Nilsson; I Rosén
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-11       Impact factor: 10.154

Review 4.  Lambert-Eaton myasthenic syndrome.

Authors:  U Seneviratne; R de Silva
Journal:  Postgrad Med J       Date:  1999-09       Impact factor: 2.401

5.  Diagnostic difficulties encountered in the myasthenic syndrome sometimes associated with carcinoma.

Authors:  J C Brown; R J Johns
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-11       Impact factor: 10.154

6.  The Eaton-Lambert syndrome masquerading as proximal myopathy.

Authors:  R J Johns; J C Brown
Journal:  Trans Am Clin Climatol Assoc       Date:  1968

7.  Eaton-Lambert syndrome: a clinical and electrophysiological study of a patient treated with 4-aminopyridine.

Authors:  D B Sanders; Y I Kim; J F Howard; C A Goetsch
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-11       Impact factor: 10.154

8.  Botulism: clinical neurophysical findings.

Authors:  R Hagenah; A Müller-Jensen
Journal:  J Neurol       Date:  1978-02-14       Impact factor: 4.849

9.  Myasthenic syndrome: effect of choline, plasmapheresis and tests for circulating factor.

Authors:  H Kranz; D J Caddy; A M Williams; W Gay
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-06       Impact factor: 10.154

10.  Cancer-associated myasthenic (Eaton-Lambert) syndrome: distribution of abnormality and effect of treatment.

Authors:  D A Ingram; G R Davis; M S Schwartz; M Traub; A C Newland; M Swash
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-08       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.